Clinical trial

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

NCT04776005

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-01-22

PhaseN/A

Study timeline

Study start (actual)2021-01-22Date precision: day

Registry last updated2024-01-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

What this registered study describes

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies is a observational study listed under registry identifier NCT04776005. Its last published status is UNKNOWN. Registry status does not establish that enrollment is currently open at every study site.

The published record lists 5 condition label(s), 1 intervention label(s), and 1 sponsor/collaborator entry or entries. The structured information below allows these links to be examined individually; intervention registration is not an efficacy claim.

Source: the original ClinicalTrials.gov study record. Always check the protocol, eligibility, dates, results (when posted), and contacts at the original source.

Conditions

Solid Tumorunresolved

Hematologic Malignancyverified · MONDO: hematopoietic and lymphoid cell neoplasm

Thoracic Cancerverified · MONDO: thoracic cancer

Cancer, Treatment-Relatedunresolved

Vaccine Response Impairedunresolved

Interventions

Data collectionOTHER

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Mapped research locations

ParisFrance2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04776005 on ClinicalTrials.gov ↗

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.